The Sailem Lab is committed to improving cancer patient outcomes by innovating computational and artificial intelligence approaches in biomedical research. Our work focuses on developing advanced deep learning techniques to discover novel diagnostic and prognostic biomarkers, which can enhance early detection and personalized treatment strategies. Furthermore, we are interested in identifying new therapeutic targets by deciphering the tumour microenvironment, providing insights into the cellular interactions that drive cancer progression. We aim to harness these insights to accelerate drug development, ultimately delivering effective therapies to patients faster.